Everolimus-Eluting Coronary Artery Stent - Vietnam Registration 2403537ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Everolimus-Eluting Coronary Artery Stent in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2403537ĐKLH/BYT-HTTB and manufactured by Purple MicroPort Cardiovascular Private Limited. The authorized representative in Vietnam is CÔNG TY TNHH VIMEDICAL.
This page provides complete technical specifications, regulatory compliance details, 3 companies making similar products including Abbott Medical, Boston Scientific Limited, and 4 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2403537ĐKLH/BYT-HTTB
000.00.04.G18-230814-0005
I-Sync - Everolimus Eluting Coronary Stent System
Technical Details
The I-Sync everolimus-coated stent system is indicated to improve the coronary lumen diameter in symptomatic patients with coronary artery disease undergoing percutaneous transluminal coronary angioplasty (PTCA) in the setting of new coronary artery disease in the native coronary arteries of eligible patients.
Dates and Status
Nov 14, 2024
Everolimus-Eluting Coronary Artery Stent
Abbott Medical
2403501ĐKLH/BYT-HTTB
Everolimus-Eluting Coronary Artery Stent
Abbott Medical
2402767ĐKLH/BYT-HTTB
Everolimus-Eluting Coronary Artery Stent
Boston Scientific Limited
2301565ĐKLH/BYT-HTTB
Everolimus-Eluting Coronary Artery Stent Frame
EVERMAX
Nano Therapeutics Pvt. Ltd.
2301266ĐKLH/BYT-HTTB